Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment

By Noriho Iida, A. Dzutsev, C. Stewart, Loretta Smith, N. Bouladoux, Rebecca A. Weingarten, D. Molina, R. Salcedo, T. Back, Sarah D. Cramer and 11 more. Science, 2013

2,030 citations recorded by the source corpus.

The Microbiota Makes for Good Therapy The gut microbiota has been implicated in the development of some cancers, such as colorectal cancer, but—given the important role our intestinal habitants play in metabolism—they may also modulate the efficacy of certain cancer therapeutics. Iida et al. (p. 967) evaluated the impact of the microbiota on the efficacy of an immunotherapy [CpG (the cytosine, guanosine, phosphodiester link) oligonucleotides] and oxaliplatin, a platinum compound used as a chemotherapeutic. Both therapies were reduced in efficacy in tumor-bearing mice that lacked microbiota, with the microbiota important for activating the innate immune response against the tumors. Viaud et al. (p. 971) found a similar effect of the microbiota on tumor-bearing mice treated with cyclophosphamide, but in this case it appeared that the microbiota promoted an adaptive immune response against the tumors. The gut microbiota promote the efficacy of several antineoplastic agents in mice. The gut microbiota influences both local and systemic inflammation. Inflammation contributes to development, progression, and treatment of cancer, but it remains unclear whether commensal bacteria affect inflammation in the sterile tumor microenvironment. Here, we show that disruption of the microbiota impairs the response of subcutaneous tumors to CpG-oligonucleotide immunotherapy and platinum chemotherapy. In antibiotics-treated or germ-free mice, tumor-infiltrating myeloid-derived cells responded poorly to therapy, resulting in lower cytokine production and tumor necrosis after CpG-oligonucleotide treatment and deficient production of reactive oxygen species and cytotoxicity after chemotherapy. Thus, optimal responses to cancer therapy require an intact commensal microbiota that mediates its effects by modulating myeloid-derived cell functions in the tumor microenvironment. These findings underscore the importance of the microbiota in the outcome of disease treatment.

Subfields: Biological Psychiatry, Immunology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/81b04a13f5862b3253da7006df7d269ecffc295b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biological Psychiatry

  1. W. Zou
  2. Y. Belkaid
  3. O. Harrison

In Immunology

  1. Guido Kroemer
  2. L. Galluzzi
  3. L. Zitvogel
  4. A. Mantovani
  5. Oliver Kepp
  6. O. Harrison
  7. P. Allavena
  8. Y. Belkaid

In Molecular Biology

  1. Guido Kroemer
  2. L. Galluzzi
  3. Oliver Kepp
  4. L. Zitvogel
  5. Y. Belkaid
  6. Ian A. Wilson
  7. Jeremy K. Nicholson
  8. Zhijian J. Chen

Citations in the corpus